XORTX Therapeutics financial statements

졸트엑스 테라퓨틱스NASDAQ:XRTX · Nasdaq · Healthcare · sector #16
$1.73+1.76%
2026-10-06 close · prelim

XORTX Therapeutics's published financial data is dated 2026-10-04. 2013 revenue was $814M. 2013 operating profit was −$2M.

Reported results

XORTX Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q